# A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic Symptoms

> **NCT03904576** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 1358894
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03904576
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-18
- **Primary completion:** 2019-08-29
- **Final completion:** 2019-08-29
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03904576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03904576, "A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic Symptoms". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03904576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*